Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)

Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)

US Patent 12178843 · Granted Dec 31, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhalable compositions comprising macrocyclic immunosuppressants2025
Inhalable compositions for use in the treatment of pulmonary diseases2025
Inhalable compositions for use in the treatment of pulmonary diseases2024
System and method for automatic emergency airway detection2023
Cyclosporine formulations for use in the prevention or treatment of pulmonary ch2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2022
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2022
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2022
Inhalable compositions for use in the treatment of pulmonary diseases2022